by Rakovina Therapeutics | Jun 26, 2025 | Uncategorized
Download Vancouver, British Columbia, June 25, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery...
by Rakovina Therapeutics | Jun 20, 2025 | Uncategorized
Download VANCOUVER, B.C., June 20, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE:7JO) (“Rakovina” or the “Company”) is pleased to announce that the effective date for the previously announced share consolidation (the...
by Rakovina Therapeutics | Jun 20, 2025 | Uncategorized
Download Vancouver, British Columbia – June 12, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery,...
by Rakovina Therapeutics | Jun 20, 2025 | Uncategorized
Download Vancouver, British Columbia – June 6, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery,...
by Rakovina Therapeutics | Jun 2, 2025 | Uncategorized
All dollar amounts reflected in Canadian dollars unless otherwise stated. Vancouver, British Columbia, June 2, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response...